Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized studyMitchell E. Horwitz, Guillermo Sanz, Amy K. Keating et al.|Blood|2021Cited by 110
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical TrialsChenyu Lin, Mitchell E. Horwitz, Aurélie Schwarzbach et al.|Transplantation and Cellular Therapy|2023Cited by 16
Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord BloodChenyu Lin, Anthony D. Sung, Gautam Sajeev et al.|Transplantation and Cellular Therapy|2022Cited by 12
Improved Clinical Outcomes with Omidubicel Versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized, Multicenter StudyMitchell E. Horwitz, Einat Galamidi, Corey Cutler et al.|Transplantation and Cellular Therapy|2021Cited by 3
CT-039 Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell Transplantation With Omidubicel Versus Standard Umbilical Cord BloodChenyu Lin, Anthony D. Sung, Gautam Sajeev et al.|Clinical Lymphoma Myeloma & Leukemia|2022Cited by 1